The Prescription Cost Analysis also highlighted that the drug with the largest i...
The committee overwhelmingly supported nirsevimab’s risk-benefit profile in both...
VEVYE is a topical anti-inflammatory and immunomodulating ophthalmic drug solution.
Upstream Bio’s UPB-101 is currently being assessed in a Phase 1b trial to treat ...
The new 244,000ft² facility represents the company’s second significant expansio...
The vaccine has been developed by WestVac Biopharma along with the West China Me...
David McInerney, Cassie Commercial Manager, explains clinical data management ch...
The Asia-Pacific pharma industry experienced a 2% rise in new job postings in Q1...
A promising therapy was pulled after four boys died. Now a company wants to sign...
"People that have to work outside all day and they already have underlying condi...
A machine that reanimates hearts could greatly expand the pool of organs for tra...
Sen. Bill Cassidy is concerned about the extended deadlines that can delay the F...
Democrats are ratcheting up their criticism of how the Biden administration is p...
Here are just a few ways in which the public health lessons of Covid may now hel...
An HHS letter obtained by STAT said the CDC's restructuring effort was not a “la...
At the BIO convention, the FDA chief asks, “How can it be that we're creating al...
